original ) (raw )Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence Level
David Bangsberg
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
View PDFchevron_right
The Rate of Viral Rebound after Attainment of an HIV Load <50 Copies/mL According to Specific Antiretroviral Drugs in Use: Results from a Multicenter Cohort Study
Kholoud Porter
The Journal of Infectious Diseases, 2005
View PDFchevron_right
Impact of Previous Virological Treatment Failures and Adherence on the Outcome of Antiretroviral Therapy in 2007
Milos Opravil
PLoS ONE, 2009
View PDFchevron_right
Predictors of short-term success of antiretroviral therapy in HIV infection
Johannes G Bode
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Antiretroviral refill histories as a predictor of future HIV viremia
Darryl Sokpa
Open Forum Infectious Diseases, 2022
View PDFchevron_right
Adherence And Plasma Drug Concentrations Are Predictors of Confirmed Virologic Response after 24-Week Salvage Highly Active Antiretroviral Therapy
Filippo Castelnuovo
AIDS Patient Care and STDs, 2007
View PDFchevron_right
A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 Suppression
David Bangsberg
The Journal of Infectious Diseases, 2006
View PDFchevron_right
Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa
Claris Shoko
Theoretical Biology and Medical Modelling
View PDFchevron_right
Four Measures of Antiretroviral Medication Adherence and Virologic Response in AIDS Clinical Trials Group Study 359
Margaret Chesney
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
View PDFchevron_right
Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
Huldrych Günthard
PLoS ONE, 2012
View PDFchevron_right
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change
Marek Beniowski
HIV Medicine, 2010
View PDFchevron_right
Predictors of Raised Viral Load during Antiretroviral Therapy in Patients with and without Prior Antiretroviral Use: A Cross-Sectional Study
Tim Spelman
PLoS ONE, 2013
View PDFchevron_right
Predictive validity of a brief antiretroviral adherence index: Retrospective cohort analysis under conditions of repetitive administration
Susanne May
AIDS Research and Therapy, 2008
View PDFchevron_right
Risk of HIV Viral Rebound in the Era of Universal Treatment in a Multi-Center Sample of Persons with HIV in Primary Care
Fizza Gillani
Open Forum Infectious Diseases, 2023
View PDFchevron_right
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations
Jane Anderson
HIV Medicine, 2010
View PDFchevron_right
Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study
Kholoud Porter
AIDS, 2008
View PDFchevron_right
Relationship between Adherence Level, Type of the Antiretroviral Regimen, and Plasma HIV Type 1 RNA Viral Load: A Prospective Cohort Study
Montse Tuset
AIDS Research and Human Retroviruses, 2008
View PDFchevron_right
The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy
David Bangsberg
PLoS ONE, 2009
View PDFchevron_right
Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?
Mervyn Tyrer
AIDS, 2002
View PDFchevron_right
HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania
Jonas P. Kessy
BMC infectious diseases, 2024
View PDFchevron_right
Returning of antiretroviral medication dispensed over a period of 8 months suggests non-adherence despite full adherence according to real time medication monitoring
Michael Ngowi
AIDS Research and Therapy, 2020
View PDFchevron_right
Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy
Marianne Harris
HIV Medicine, 2002
View PDFchevron_right
The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus–Infected Persons in Clinical Trials
Margaret Chesney
Clinical Infectious Diseases, 2002
View PDFchevron_right
Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Suppression: Five-Year Follow Up of an Observational Cohort
Tim Spelman
PLOS One, 2010
View PDFchevron_right
Incidence and Predictors of Virologic Failure of Antiretroviral Triple-Drug Therapy in a Community-Based Cohort
Milos Opravil , Daniel H Paris
Aids Research and Human Retroviruses, 1999
View PDFchevron_right
Evaluating HIV Viral Rebound Among Persons on Suppressive Antiretroviral Treatment in the Era of “Undetectable Equals Untransmittable (U = U)”
Su Su Aung
Open Forum Infectious Diseases, 2020
View PDFchevron_right
The Adherence to Fixed-Dose Combination Antiretroviral Therapy and Viral Load in HIV Patients
NURFITRI BUSTAMAM
Mutiara Medika: Jurnal Kedokteran dan Kesehatan, 2020
View PDFchevron_right
High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial
P. Mugyenyi
PLoS ONE, 2014
View PDFchevron_right
A Prospective Study of Adherence and Virologic Failure in HIV-Infected Patients: Role of a Single Determination of Plasma Levels of Antiretroviral Medications
Vicente MARTÍN SÁNCHEZ
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 2007
View PDFchevron_right
Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study
Margaret Chesney
Archives of Internal Medicine, 2001
View PDFchevron_right
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome
Ivana Maida
Journal of Antimicrobial Chemotherapy, 2008
View PDFchevron_right